The Sensex surged by 1859.88 points, opening at a record 75,821.19....
Category:
Indian News
Latest
Markets may reach new heights on Monday, but investors should invest for long term in quality stocks
Porinju Veliyath, Founder - Equity Intelligence noted that there...
Sweltering heat directs attention at ‘disappearing’ spring in country
Such extreme heat has wide-ranging consequences on public health,...
Delhi govt advertises for 60 environmental scientists
“Delhi cannot build a wall to prevent polluted air coming from its surrounding states, but it has to check its own sources of pollution – be it dust, illegal industries, polluting factories, polluting vehicles or waste and biomass burning,” said Vimlendu Jha, founder of environment group Swechha.
Indian economy contracts 7.5 pc in Q2, recovery seen next year
Economists have marginally raised growth forecasts this month after a pick-up in consumer demand for autos, non-durables and rail freight during the festival season.
“The possibility of a release of several highly effective vaccines soon gives us hope that there is an end date to the pandemic Rumki Majumdar, economist at Deloitte India, while expressing confidence in a quick economic rebound.
International passenger flights to remain suspended till December 31
However, these restrictions won’t apply to cargo operations and services approved by the DGCA.
The DGCA also added that select international flights on limited routes may be allowed by competent authorities on case to case basis.
Mamata announces health scheme for all in WB
The scheme, officially launched by Banerjee in December 2016 is a basic health cover for secondary and tertiary care up to Rs five lakh per annum per family.
India records 44,489 new coronavirus cases
The active cases comprise 4.88 per cent of the total caseload, the data stated.
The total number of people who have recuperated from the disease surged to 86,79,138, pushing the national recovery rate to 93.66 per cent, while the Covid-19 case fatality rate stands at 1.46 per cent.
Govt launches ‘Mission Covid Suraksha’ to help accelerate vaccine candidates
The mission envisages Covid-19 vaccine development with end-to-end focus from preclinical through clinical development and manufacturing and regulatory facilitation, the DBT said.
Earlier this month, the government had announced a package of Rs 900 crore for vaccines.
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Besides, Covaxin, four other vaccines are under different phases of clinical trial in India with the Serum Institute of India conducting phase-three trial of the Oxford-Astrazeneca Covid-19 vaccine while the indigenously developed vaccine by Zydus Cadila has completed phase-two clinical trial in the country.
Over 50,000 Ayushman Bharat Health and Wellness Centres operational across country
AstraZeneca faces more Covid-19 vaccine questions after manufacturing error
In a statement, Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one. When it was apparent that a lower dose was used, it was discussed with regulators, and an agreement was reached to push ahead with the two regimens, the statement said.
Skoda India’s plea to quash FIR for alleged use of cheat device dismissed
The FIR was also lodged in UP and the company moved the high court seeking its quashing, it said.
The apex court passed the order on the appeal filed by Skoda against the Allahabad High Court order refusing to quash the FIR and dismissing its plea.